Sign in

Eileen Mallesch

Director at Brighthouse FinancialBrighthouse Financial
Board

About Eileen A. Mallesch

Independent director of Brighthouse Financial (BHF) since 2018; age 69. Former senior finance executive with CFO roles at Nationwide Mutual Insurance (P&C business) and GE/Genworth; BS from City University of New York; member of the American Institute of CPAs. Core credentials span accounting/financial reporting, insurance, financial services, and investments; currently chairs BHF’s Investment Committee and serves on Compensation & Human Capital and Nominating & Corporate Governance Committees .

Past Roles

OrganizationRoleTenureNotes
Nationwide Mutual Insurance CompanySVP & CFO, Property & Casualty2005–2009Insurance finance leadership
Genworth Financial Life Insurance Company (GE)SVP & CFO2003–2005Life insurance finance
GE Financial Employer Services GroupVP & CFO2000–2003Employer services finance
GE AmericomController1998–2000Satellite services
Asea Brown Boveri (ABB)International Business Area Controller, Energy Ventures1993–1998Industrial/energy finance
PepsiCoFinance roles1988–1993Consumer sector experience
Arthur AndersenProfessional staff1985–1988Public accounting foundation

External Roles

OrganizationRoleTenureCommittees/Impact
Arch Capital Group Ltd.Director2021–presentNot disclosed in BHF proxy
Fifth Third BancorpDirector2016–presentNot disclosed in BHF proxy
State Auto Financial CorporationDirector (past)2010–2021Past service
Libbey Inc.Director (past)2016–2020Past service
Bob Evans Farms, Inc.Director (past)2008–2018Past service

Board Governance

  • Committee assignments: Investment (Chair), Compensation & Human Capital, Nominating & Corporate Governance .
  • Committee activity: Investment Committee met 5 times in 2024; Compensation & Human Capital 6; Nominating & Corporate Governance 5 .
  • Independence: Board determined all directors except the CEO are independent; Mallesch is independent .
  • Attendance: In 2024, Board held 7 meetings and Committees 34; each director attended at least 75% of Board and committee meetings on which they served .
  • Election results (2025 Annual Meeting): For 37,588,862; Against 168,410; Abstain 55,966; Broker non-vote 5,227,857 .
  • Shareholder sentiment: Say‑on‑Pay approval in 2025—For 35,210,082; Against 2,536,631; Abstain 66,525—indicates broad support for compensation governance .
  • Hedging/pledging: Insider trading policy prohibits hedging and pledging for employees and directors .
  • Overboarding policy: Limits are three other public company boards; BHF confirms compliance across directors .

Fixed Compensation

ComponentAmountFormNotes
Annual director retainer (program)$285,000$120,000 cash; $165,000 equityStandard for non‑management directors
Investment Committee Chair fee (program)$22,000CashApplies to Mallesch as chair
2024 cash received (actual)$142,000CashRetainer + chair fee
Meeting feesNone disclosedNot in program table

Performance Compensation

Equity AwardGrant DateUnitsGrant-Date Fair ValueVesting Terms
Annual RSUs (2024)June 6, 20243,850$164,973Vest on earlier of one-year anniversary or next annual meeting
Annual Chair RSUs (Chair receives equity only for Chairman of Board; not applicable to Mallesch)Only Board Chairman has 50% equity for chair stipend
  • Program design: Annual director RSUs sized to intended value ($165,000), with units determined by closing price at grant; prorated for mid‑cycle appointments .
  • Change-in-control treatment (pending transaction): Company’s Nov 6, 2025 8‑K indicates outstanding service‑based RSUs will become fully vested at closing and convert to cash at the merger consideration per unit (disclosed as $70 in employee communications), which may be viewed as single‑trigger vesting for equity awards .

Other Directorships & Interlocks

Potential Interlock AreaObservationImplication
Financial services/insuranceCurrent roles at Arch Capital (insurance) and Fifth Third (bank) Monitor any business dealings; BHF’s Related Person Transaction policy governs approvals . No Mallesch‑specific related transactions are disclosed in the provided proxy sections .

Expertise & Qualifications

  • Skills: Accounting/financial reporting, insurance, financial services, investments .
  • Designations: AICPA member .
  • Governance: Chairs Investment Committee overseeing enterprise investment strategy, EIAs, external asset manager oversight .

Equity Ownership

HolderShares Beneficially Owned% of Common StockRSUs Vesting Within 60 Days Included?
Eileen A. Mallesch22,585*Yes—3,850 RSUs within 60 days of April 14, 2025
All directors & officers (14 persons)822,3131.4%See footnotes in proxy
  • Director stock ownership guidelines: Each independent director expected to acquire shares equal to at least 4× the equity portion of the annual retainer; 5‑year compliance window; directors >5 years are in compliance; others on track. As of record date, no director has sold vested equity .
  • Engagement signal: Directors are expected to attend annual meetings; 2024 attendance met expectations .

Governance Assessment

  • Strengths:

    • Independent status; chair of Investment Committee with direct oversight of investment authorities and external managers—aligned with BHF’s risk and capital‑intensive profile .
    • Solid attendance and committee workload; clear skills fit for insurance/financial reporting; long‑tenured board member providing continuity .
    • Ownership alignment via RSUs; adherence to robust director ownership guidelines; hedging/pledging prohibited .
    • Shareholder support evidenced by strong election tallies and broad Say‑on‑Pay approval .
  • Watch items / potential red flags:

    • Single‑trigger vesting/cash‑out of RSUs at change‑in‑control in 8‑K could be viewed as reducing long‑term holding alignment around a transaction; monitor final treatment for director awards at close .
    • External board commitments at two public companies (Arch Capital, Fifth Third) are within BHF’s overboarding limits; nonetheless, watch for any related‑party exposures or information flow conflicts—BHF’s policy requires committee review of such transactions, and no Mallesch‑specific related transactions are shown in provided sections .